Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers

作者：Nakajima Hiroo; Sakaguchi Koichi; Fujiwara Ikuya; Mizuta Mitsuhiko; Tsuruga Mie; Magae Junji^*; Mizuta Naruhiko

来源：Biochemical and Biophysical Research Communications, 2007, 356(1): 260-265.

DOI：10.1016/j.bbrc.2007.02.136

• tetrocarcin A
• PTEN
• PI3-kinase
• PDKI
• Akt
• breast cancer
• apoptosis
• phosphorylation
• dephosphorylation
• survival factor
• BcI-2
• BcL-x(L)
• caspase

A survival kinase, Akt, is a downstream factor in the phosphatidylinositide-3'-kinase-dependent pathway, which mediates many biological responses including glucose uptake, protein synthesis and the regulation of proliferation and apoptosis, which is assumed to contribute to acquisition of malignant properties of human cancers. Here we find that an anti-tumor antibiotic, tetrocarcin A, directly induces apoptosis of human breast cancer cells. The apoptosis is accompanied by the activation of a proteolytic cascade of caspases including caspase-3 and -9, and concomitantly decreases phosphorylation of Akt, PDK1, and PTEN, a tumor suppressor that regulates the activity of Akt through the dephosphorylation of polyphosphoinositides. Tetrocarcin A affected neither expression of Akt, PDK1, or PTEN, nor did it affect the expression of Bcl family members including Bcl-2, Bcl-X-L, and Bax. These results suggest that tetrocarcin A could be a potent chemotherapeutic agent for human breast cancer targeting the phosphatidylinositide-3'-kinase/Akt signaling pathway.

• 出版日期2007-4-27